Conventional chemotherapy for acute myeloid leukemia: a Brazilian experience
São Paulo med. j
; 118(6): 173-8, Nov. 2000. graf, tab
Article
en En
| LILACS
| ID: lil-277625
Biblioteca responsable:
BR1.1
ABSTRACT
CONTEXT Young patients affected by acute myeloid leukemia (AML) achieve complete remission (CR) using conventional chemotherapy in about 55-85 percent. However, 30 percent of patients fail to achieve CR and the remission duration is often only about 12 months. More intensive treatment after CR seems to be necessary in order to maintain CR and obtain a definitive cure. In Brazil, few reports have been published on this important subject. OBJECTIVE:
The aim of this study was to describe a Brazilian experience in the treatment of "de novo" acute myeloid leukemia (AML) in younger adult patients (age < 60 years).DESIGN:
Retrospective analysis.SETTING:
University Hospital, Hematology and Hemotherapy Center, State University of Campinas, Brazil...
Texto completo:
1
Bases de datos:
LILACS
Asunto principal:
Protocolos de Quimioterapia Combinada Antineoplásica
/
Leucemia Mieloide
Tipo de estudio:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
País/Región como asunto:
America do sul
/
Brasil
Idioma:
En
Revista:
São Paulo med. j
Asunto de la revista:
Cirurgia Geral
/
Cincia
/
Ginecologia
/
MEDICINA
/
Medicina Interna
/
Obstetr¡cia
/
Pediatria
/
Sa£de Mental
/
Sa£de P£blica
Año:
2000
Tipo del documento:
Article
País de afiliación:
Brasil